HIV-1-infected children on HAART: Immunologic features of three different levels of viral suppression

Cytometry Part B - Clinical Cytometry

Volumn 72, Issue 1, 2007, Pages 14-21

  Zaccarelli Filho, Carlos Alberto ^a   Ono, Erika ^a   Machado, Daisy Maria ^a   Brunialti, Milena ^a   De Menezes Succi, Regina Célia ^a   Salomão, Reinaldo ^a   Kallás, Esper Georges ^a   De Moraes Pinto, Maria Isabel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antiretroviral therapy; HIV infected children; Immune reconstitution

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DIPHTHERIA ANTIBODY; HEPATITIS B ANTIBODY; MEASLES ANTIBODY; RUBELLA ANTIBODY; TETANUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE ACTIVATION; TREATMENT RESPONSE; VIRUS IMMUNITY; VIRUS INHIBITION; VIRUS LOAD;

AIDS VACCINES; ANTIBODIES; ANTIGENS, CD; ANTIGENS, CD5; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CHILD; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; INTEGRIN ALPHA CHAINS; KILLER CELLS, NATURAL; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; THYMUS GLAND; VIRAL LOAD;

EID: 33846193661     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.20152     Document Type: Article

References (49)

1. Li TS, Tubiana R, Katlama C, Calvez V, Mohand HA, Autran B. Long-lasting recovery in CD4 T-cell function and viral load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-1686.
2. + T cell homeostasis and function in advanced HIV disease. Science 1997;277: 112-116.
3. So CH, Oleske JM, Brady MT, Spector SA, Borkowki W, Burchett SK, et al. Long-term effects of protease-inhibitor-based combination therapy on CD4 T-cell recovery in HIV-1-infected children and adolescents. Lancet 2003;362:2045-2051.
4. Gibb DM, Newberry A, Klein N, de Rossi A, GroschWoerner, Babiker A. Immune repopulation after HAART in previously untreated HIV-1-infected children. Lancet 2000;355:1331-1332.
5. Kaufmann GR, Zaunders JJ, Cunningham P, Kelleher AD, Grey P, Smith D, et al. Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection. AIDS 2000;14:2643-2651.
6. Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, St. Clair M, et al. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine and ritonavir: Results of AIDS clinical groups protocol 315. J Infect Dis 1998;178:70-79.
7. Lederman MM, McKinnis R, Kelleher D, Cutrell A, Mellors J, Neisler M. Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: Age inversely predicts naÿve CD4 cell count increase. AIDS 2000;14:2635-2642.
8. Mezzaroma I, Carlesimo M, Pinter E, Alario C, Sacco G, Santini M, et al. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease. AIDS 1999;13:1187-1193.
9. Hinaut M, Ducarme M, Schandené L, Peltier CA, Marissens D, Zissis G, et al. Age-related reconstitution during highly active antiretroviral therapy on human immunodeficiency virus type-1-infected children. Pediatr Infect Dis J 2003;22:62-69.
10. Van Rossum AMC, Scherpbier HJ, van Lochem EG, Pakker NG, Slicker WA, Wolthers KC, et al. Therapeutic immune reconstitution in HIV-1-infected children is independent of their age and pretreatment immune status. AIDS 2001;15:2267-2275.
11. Resino S, Navarro J, Bellón M, Gurbindo D, Leon JA, MunozFernandez MA. Naive and memory CD4+ T cell activation markers in HIV-1 infected children on HAART. Clin Exp Immunol 2001;125:266-273.
12. Essajee S, Kim M, Gonzalez C, Rigaud M, Kaul A, Chandwani S, et al. Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children. AIDS 1999;13:2523-2532.
13. King DJS, Gotch FM, Larson-Sciard EL. T-cell re-population in HIV-infected children on highly active anti-retroviral therapy (HAART). Clin Exp Immunol 2001;125:447-454.
14. Gulick RM, Mellors JW, Havlir D, Eron JJ, Gonzalez C, McMahon D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997;337:734-739.
15. Starr SE, Fletcher CV, Spector SA, Yong FH, Fenton T, Brundage RC, et al. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. N Engl J Med 1999;341:1874-1881.
16. Van Rossum AMC, Fraaji PLA, de Groot R. Efficacy of highly active antiretroviral therapy in HIV-1 infected children. Lancet Infect Dis 2002;2:93-102.
17. Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, et al. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N Engl J Med 1997;336: 1337-1342.
18. Harari A, Rizzardi P, Ellefsen K, Ciuffreda D, Champagne P, Bart PA, Kaufmann D, et al. Analysis of HIV-1 and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 2002;100:1381-1387.
19. Geginat J, Lanzavecchia A, Sallusto F. Proliferation and differentiation potential of human CD8+ memory T cell subsets in response to antigen or homeostatic cytokines. Blood 2003;101:4260-4266.
20. McFarland R, Douek D, Koup RA, Picker LJ. Identification of a human thymic emigrant phenotype. Proc Natl Acad Sci USA 2000;97: 1215-1220.
21. Ibegbu C, Spira T, Nesheim S, Mendez H, Lee F, Polliotti B, Caba J, Nahmias A. Subpopulations of T and B cells in perinatally HIV-infected children compared with those in adults. Clin Immunol Imunopathol 1994;71:27-32.
22. Kristiansen M, Aggerbeck H, Heron I. Improved ELISA for determination of anti-diphteria and/or tetanus antitoxin antibodies in sera. APMIS 1997;105:843-853.
23. de Moraes-Pinto MI, Almeida AC, Kenj G, Filgueiras TE, Tobias W, Santos AM, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996;173:1077-1084.
24. Galazka AM. The immunological basis for immunization series. Module 3: Tetanus. World Health Organization, Geneva; 1993. WHO/EPI/ GEN/93.13.
25. Galazka AM. The immunological basis for immunization series. Module 2: Diphtheria. World Health Organization, Geneva; 1993. WHO/ EPI/GEN/93.12.
26. Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA. Measles antibody: Reevaluation of protective titers. J Infect Dis 1990;162:1036-1042.
27. Centers for Disease Control and Prevention. Control and prevention of rubella: Evaluation and management of suspected outbreaks, rubella in pregnant women, and surveillance for congenital rubella syndrome. MMWR 2001;50:1-23.
28. American Academy of Pediatrics. Hepatitis B. In: Pickering LK, editor. Red Book: 2003 Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003. pp 318-336.
29. Fauci A. HIV and AIDS: 20 years of science. Nat Med 2003;9:839-843.
30. Dalgleish AG, Beverly PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312:763-767.
31. Abbas AK, Litchman AH. Cellular and Molecular Immunology. Philadelphia: Saunders; 2003.562 p.
32. Clerici M, Shearer GM. A Th1-Th2 swicth is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-111.
33. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.
34. Resino S, Correa R, Bellón JM, Munoz-Fernandez, Muñoz-Fernández MA. Preserved immune system in long-term asymptomatic vertically HIV-1 infected children. Clin Exp Immunol 2003;132:105-112.
35. Lange CG, Lederman MM, Medvik K, et al. Nadir CD4+ T cell count and numbers of CD28+ CD4+ T cells predicts functional responses to immunization in chronic HIV-1 infection. AIDS 2003;17:2015-2023.
36. Harari A, Vallelian F, Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 2004;34:3525-3533.
37. + T cells responses are not restored by antiretroviral therapy. J immunol 2004;173:2184-2189.
38. Plaeger-Marshall S, IsacescuV, O'Rourke S, Bertolli J, Bryson YJ, Stiehm ER. T cell activation in pediatric AIDS pathogenesis: Three-color immunophenotyping. Clin Immunol Immunopathol 1994;71:19-26.
39. McLoskey TW, Cavaliere T, Bakshi S, Harper R, Fagin J, Kohn N, Pahwa. Immunophenotyping by three color flow cytometry in healthy newborns children and adults. Clin Immunol Immonopathol 1997;84:46-55.
40. Deeks S, Kitchen CMR, Liu L, Guo H, Gascon R, Narváez AB, et al. Immune activation set-point during early infection predicts subsequent CD4+ T cell changes independent of viral load. Blood 2004; 104:942-947.
41. Sherman GG, Scott LE, Galpin JS, Kuhn L, Tiemessen CT, Simmank K, et al. CD38 expression on CD8+ T cells as a prognostic marker in vertically HIV- infected pediatric patients. Pediatr Res 2002;51:740-745.
42. Shindu STAK, Ahmad R, Blagdon M, Ahmad A, Toma E, Morisset R, et al. Virus load correlates inversely with the expression of citotoxic T lymphocyte activation markers in HIV-1-infected/ AIDS patients showing MHC-unrestricted CTL-mediated lysis. Clin Exp Immunol 2003; 132:120-127.
43. Schlesinger M, Peters V, Dond J, Roboz JP, Bekesi JG. Increased expression of activation markers on CD8 lymphocytes in children with human immunodeficiency virus-1 infection. Pediatr Res 1995;38:390-396.
44. Liu Z, Hultin L, Cumberland WG, Hulting P, Schmid, MatudJL, Detelas R, et al. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells id a marker of poor prognosis in HIV infection: Results of a 6 year follow up. Cytometry 1996;26:1-7.
45. Ibegbu CC, Nahmias AJ, Spira TJ, Stoll BJ, Jones B, Symbas N, Nesheim S, Mendez, et al. CD5+ B cells in normal newborns and infants, and in those with HIV intrauterine infections. Ann N Y Acad Sci 1992;651:572-575.
46. Bonetti TCS, Succi RCM, Weckx LY, Tavares-Lopes L, de Moraes-Pinto MI. Tetanus and diphtheria antibodies and response to a booster dose in Brazilian HIV-1-infected women. Vaccine 2004;22: 3707-3712.
47. Newell ML, Patel D, Goetghebuer T, Thorne C; European Collaborative Study. CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: Is it associated with age at initiation? Infect Dis 2006;193:954-962.
48. Resino S, Alvaro-Meca A, de Jose I, Martin-Fontelos P, Gutierrez MD, Leon JA, Ramos JT, Ciria L, Munoz-Fernandez MA. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency. Pediatr Infect Dis J 2006;25:365-368.
49. Resino S, Resino R, Micheloud D, Gurbindo Gutierrez D, Leon JA, Ramos JC, Ciria L, de Jose I, Mellado J, Munoz-Fernandes A; Spanish Group of Paediatric HIV infection. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type1-infected children: 6 years of follow-up. Clin Infect Dis 2006;42:862-869.